http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2648053-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac6817bbdd3c6ef1531db8defbd20540
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7015
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2010-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_263e785360e40e125871b6d0a216aff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f858403ef5ed0d53558ea02db4f8ab2
publicationDate 2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2648053-T3
titleOfInvention Neuropathic Pain Treatment Procedure
abstract A local solid-forming anesthetic formulation comprising: a local anesthetic comprising lidocaine, tetracaine, prilocaine, ropivacaine or bupivacaine or mixtures thereof, in which the total amount of local anesthesia is 4% by weight to 15% by weight. weight based on the total formulation, from 12% by weight to 30% by weight of polyvinyl alcohol and water characterized in that the ratio of water to polyvinyl alcohol is greater than 2.5.
priorityDate 2009-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70687305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452716201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414876235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426359782

Total number of triples: 53.